Methyl-phenyl-tetrahydro-pyridine (MPTP) is best described as which of the following?

Prepare for the American Board of Professional Psychology (ABPP) Exam with flashcards and multiple-choice questions. Each question includes insights and explanations to help you excel. Get ready for your certification journey!

Multiple Choice

Methyl-phenyl-tetrahydro-pyridine (MPTP) is best described as which of the following?

Methyl-phenyl-tetrahydro-pyridine is best described as a neurotoxic compound that produces a Parkinson-like syndrome by selectively damaging dopaminergic neurons. It is metabolized in the brain by MAO-B in glial cells to the active metabolite MPP+, which is taken up by dopaminergic neurons via the dopamine transporter and then inhibits mitochondrial complex I. This disrupts cellular energy production and leads to neuronal death, the hallmark of parkinsonian pathology. The toxin’s action explains why it’s used to create animal models of Parkinson’s disease for research. It is not a supplement like Coenzyme Q10, nor a treatment like L-dopa, nor a disease such as MSA.

Methyl-phenyl-tetrahydro-pyridine is best described as a neurotoxic compound that produces a Parkinson-like syndrome by selectively damaging dopaminergic neurons. It is metabolized in the brain by MAO-B in glial cells to the active metabolite MPP+, which is taken up by dopaminergic neurons via the dopamine transporter and then inhibits mitochondrial complex I. This disrupts cellular energy production and leads to neuronal death, the hallmark of parkinsonian pathology. The toxin’s action explains why it’s used to create animal models of Parkinson’s disease for research. It is not a supplement like Coenzyme Q10, nor a treatment like L-dopa, nor a disease such as MSA.

More practice questions